Treatment of advanced bronchogenic carcinoma with adriamycin and 5-fluorouracil.
Thirty patients with an advanced bronchogenic carcinoma were treated with a combination of adriamycin and 5-fluorouracil; in eight the size of the tumour or its metastases was reduced by over 50%, and eight further patients experienced useful relief of symptoms. This drug combination is useful in the magagement of lung cancer.
D000505:Alopecia / Q000139:chemically induced; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011655:Pulmonary Embolism / Q000209:etiology; D013280:Stomatitis / Q000139:chemically induced; D014684:Venae Cavae / Q000473:pathology
D004317:Doxorubicin; D005472:Fluorouracil